Description

Mazdutide Peptide for Advanced Dual GLP-1R and GCGR Receptor Research.

Mazdutide Peptide (IBI362/LY3305677) is an investigational dual agonist designed to activate both the GLP-1 receptor (GLP-1R) and the glucagon receptor (GCGR) through a single peptide molecule. Derived from the endogenous hormone oxyntomodulin, Mazdutide incorporates strategic amino acid substitutions that enhance enzymatic stability while maintaining balanced activity across both receptor systems, making it an important research tool for studying dual incretin biology.

Scientific investigations utilize Mazdutide Peptide in endocrinology, molecular pharmacology, metabolism, receptor biology, and peptide chemistry to examine receptor binding kinetics, intracellular signaling pathways, metabolic regulation, mitochondrial function, peptide pharmacokinetics, and endocrine communication. Researchers also investigate downstream signaling involving cyclic AMP (cAMP), protein kinase A (PKA), AMP-activated protein kinase (AMPK), lipid metabolism, glucose homeostasis, and energy regulation under controlled laboratory conditions.

Its dual receptor activity enables simultaneous investigation of complementary signaling pathways while supporting comparative studies with selective GLP-1 receptor agonists, glucagon receptor agonists, and other multi-receptor peptide analogs. Universities, biotechnology companies, pharmaceutical organizations, and life science laboratories utilize Mazdutide Peptide as a reference compound for receptor pharmacology, translational biology, and molecular signaling research.

Each batch is synthesized under stringent quality-controlled manufacturing procedures, analytically verified for purity and structural integrity, and supplied as a stable lyophilized peptide accompanied by a comprehensive Certificate of Analysis to ensure reproducible laboratory investigations.

For research use only. Not intended for human consumption or clinical use.

Key Research Highlights

• Synthetic 39-amino-acid dual receptor agonist
• Optimized oxyntomodulin-derived peptide analog
• Dual activation of GLP-1R and GCGR
• Extensively investigated in incretin receptor biology
• Frequently utilized in metabolic signaling research
• Evaluated in endocrine pathway investigations
• Studied in receptor pharmacology and peptide chemistry
• High-purity lyophilized peptide suitable for laboratory applications
• Certificate of Analysis (COA) supplied with every batch
• Manufactured under stringent analytical quality standards
• Excellent batch-to-batch reproducibility
• Suitable for biotechnology, pharmaceutical, and academic research laboratories

Why Researchers Choose This Product

• ≥98% research-grade purity verified through analytical testing
• Verified dual receptor agonist sequence
• High affinity for GLP-1R and GCGR
• Stable lyophilized formulation for laboratory storage
• Comprehensive Certificate of Analysis included
• Reliable reproducibility across experimental investigations
• Suitable for endocrinology and receptor pharmacology research
• Manufactured using rigorous peptide synthesis protocols
• Excellent analytical consistency between production batches
• Intended exclusively for scientific laboratory investigations

Research Applications

Dual Incretin Receptor Biology

Mazdutide Peptide is extensively utilized in laboratory investigations examining coordinated activation of GLP-1R and GCGR, receptor pharmacology, ligand binding, receptor trafficking, and downstream intracellular signaling.

Metabolic Biology

Researchers employ Mazdutide to investigate glucose metabolism, lipid metabolism, cellular bioenergetics, substrate utilization, mitochondrial function, and endocrine regulation in controlled experimental systems.

Molecular Endocrinology

Experimental models utilize Mazdutide Peptide to study cyclic AMP signaling, protein kinase activation, endocrine communication, transcriptional regulation, and receptor-mediated cellular responses.

Receptor Pharmacology

Scientists investigate receptor selectivity, agonist efficacy, signal amplification, ligand-receptor kinetics, receptor internalization, and comparative pharmacological profiles.

Peptide Pharmacokinetics

Laboratory investigations examine peptide stability, enzymatic degradation resistance, molecular persistence, formulation characteristics, and analytical performance.

Peptide Chemistry

Researchers utilize Mazdutide Peptide for analytical characterization, formulation development, structure-activity relationship studies, medicinal chemistry, and quality control validation.

Product Specifications

Mechanism of Action

Mazdutide Peptide is a synthetic dual agonist engineered to activate both the glucagon-like peptide-1 receptor (GLP-1R) and the glucagon receptor (GCGR). Structurally derived from the endogenous peptide oxyntomodulin, Mazdutide incorporates sequence modifications that enhance enzymatic stability while preserving balanced receptor affinity, allowing researchers to investigate coordinated activation of two closely related Class B G protein-coupled receptors (GPCRs).

Upon binding to GLP-1R, Mazdutide activates Gs proteins, stimulating adenylyl cyclase and increasing intracellular cyclic adenosine monophosphate (cAMP) concentrations. Elevated cAMP activates protein kinase A (PKA) and exchange proteins directly activated by cAMP (EPAC), initiating signaling cascades that regulate transcriptional activity, intracellular calcium handling, vesicle trafficking, and endocrine cell communication in experimental models.

Simultaneously, activation of GCGR initiates complementary Gs-mediated signaling pathways that also elevate intracellular cAMP while influencing additional transcriptional programs associated with cellular energy metabolism, mitochondrial function, oxidative phosphorylation, and substrate utilization. Researchers frequently investigate interactions between GLP-1R and GCGR signaling because coordinated receptor activation produces distinct molecular responses compared with selective agonism of either receptor alone.

Published laboratory investigations have demonstrated downstream modulation of signaling pathways involving AMP-activated protein kinase (AMPK), PI3K/Akt, MAPK/ERK, CREB, and PGC-1α, providing valuable experimental models for studying receptor cross-talk, intracellular signaling integration, mitochondrial biology, and metabolic pathway regulation. Researchers also utilize Mazdutide to evaluate receptor internalization, ligand bias, signal duration, pharmacodynamic characteristics, and comparative receptor pharmacology.

Its defined molecular architecture, reproducible biochemical properties, and dual receptor activation profile have established Mazdutide Peptide as an important experimental reagent for endocrinology, molecular pharmacology, receptor biology, peptide chemistry, biotechnology, and life science laboratories investigating incretin signaling and integrated metabolic regulatory networks.

For research use only. Not intended for human consumption or clinical use.